Last edition
News about "Synthetic CBD therapy"
Leiutis Pharma Wins CDSCO Approval for World's First Synthetic CBD Anxiety Therapy
Leiutis Pharmaceuticals has received CDSCO approval for the world's first synthetic CBD oral solution to treat mild to moderate anxiety disorders alongside cognitive behavioral therapy.
Synthetic CBD Therapy | 15/07/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members